Providence Capital Advisors, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1730814
CHARLOTTE, NC
Position in BMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,729,507
-$264,292 QoQ
Shares Held
82,081
-0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#556
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. BMY ranks #3 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,729,507 | 82,081 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,993,799 | 82,338 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,319,137 | 80,073 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,486,951 | 77,316 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,466,519 | 74,887 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,245,399 | 53,212 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,968,268 | 52,480 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,703,880 | 52,259 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,158,853 | 51,983 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,775,816 | 51,186 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,874,918 | 36,541 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,216,199 | 38,184 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,384,183 | 37,282 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,540,627 | 36,656 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $2,588,904 | 35,982 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,560,590 | 36,019 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,725,030 | 35,390 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,485,576 | 34,035 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,973,128 | 31,646 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,785,987 | 30,184 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,873,766 | 28,042 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,606,532 | 25,448 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,480,718 | 23,871 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,193,742 | 19,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,138,426 | 19,361 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $5,574 | 100 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||